SIGLEC1 and COVID-19: The intermediate monocytes (consistently present in COVID-19) were characterized by a pronounced antiviral, interferon-driven response, as illustrated by the upregulation of both interferon-inducible and stimulated genes (IFI6, IFI27, IFI44L, and ISG15, SIGLEC1; Figure 5c,e).